ホーム › 脂肪肝 › テキサス › San Antonio
San Antonio、TXにおける脂肪肝の臨床試験
San Antonioとその周辺地域（約30マイル以内）の拠点で、脂肪肝に関する17件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
被験者募集中第3相
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
被験者募集中第3相
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- 他2件
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
被験者募集中第3相
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
被験者募集中第3相
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
被験者募集中第2相
- American Research Corporation at The Texas Liver Institute, San Antonio
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
被験者募集中第2相
- American Research Corporation at The Texas Liver Institute, San Antonio
- Pinnacle Clinical Research - San Antonio, San Antonio
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
被験者募集中第3相
- American Research Corporation at Texas Liver Institute, San Antonio
- Clinical Trials of Texas, LLC dba Flourish Research, San Antonio
- IMA Clinical Research San Antonio, San Antonio
- 他1件
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
被験者募集中第3相
- Akero Clinical Study Site, San Antonio
- Akero Clinical Study Site, San Antonio
- Akero Clinical Study Site, San Antonio
- 他2件
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
被験者募集中第3相
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
被験者募集中第2相
- Quality Research, Inc., San Antonio
- Pinnacle Clinical Research - South San Antonio, San Antonio
- Pinnacle Clinical Research, San Antonio
Quantifying Hepatic Mitochondrial Fluxes in Humans
被験者募集中第4相
- Texas Diabetes Institute - University Health System, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
被験者募集中第2相
- GSK Investigational Site, San Antonio
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
被験者募集中第3相
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
被験者募集中第2相
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
被験者募集中第1相
- GSK Investigational Site, San Antonio
Evaluating the Pharmacokinetics and Safety of Miricorilant
被験者募集中第1相
- Site# 433, San Antonio
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
被験者募集中観察研究
- Endeavor Clinical Trials, San Antonio
他の都市における脂肪肝の試験
- Miami, FL16件の研究
- New York City, NY16件の研究
- San Diego, CA14件の研究
- Austin, TX13件の研究
- Houston, TX13件の研究
- Richmond, VA12件の研究
- Chandler, AZ10件の研究
- Tucson, AZ10件の研究
- St. Louis, MO9件の研究
- Dallas, TX9件の研究
- Orlando, FL9件の研究
- Hialeah, FL9件の研究
San Antonioにおける他の研究
- 非小細胞肺癌59件の研究
- 乳がん47件の研究
- 大腸癌46件の研究
- 転移性癌44件の研究
- がん（全種類）41件の研究
- 肥満症40件の研究
- 2型糖尿病37件の研究
- 過体重34件の研究
- 卵巣がん31件の研究
- 膵臓がん31件の研究
- 前立腺がん28件の研究
- 子宮内膜がん27件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。